Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice
Jun Xu, … , George F. Koob, Tatiana Kisseleva
Jun Xu, … , George F. Koob, Tatiana Kisseleva
Published February 13, 2020
Citation Information: JCI Insight. 2020;5(3):e131277. https://doi.org/10.1172/jci.insight.131277.
View: Text | PDF
Research Article Gastroenterology

Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice

  • Text
  • PDF
Abstract

Chronic alcohol abuse has a detrimental effect on the brain and liver. There is no effective treatment for these patients, and the mechanism underlying alcohol addiction and consequent alcohol-induced damage of the liver/brain axis remains unresolved. We compared experimental models of alcoholic liver disease (ALD) and alcohol dependence in mice and demonstrated that genetic ablation of IL-17 receptor A (IL-17ra–/–) or pharmacological blockade of IL-17 signaling effectively suppressed the increased voluntary alcohol drinking in alcohol-dependent mice and blocked alcohol-induced hepatocellular and neurological damage. The level of circulating IL-17A positively correlated with the alcohol use in excessive drinkers and was further increased in patients with ALD as compared with healthy individuals. Our data suggest that IL-17A is a common mediator of excessive alcohol consumption and alcohol-induced liver/brain injury, and targeting IL-17A may provide a novel strategy for treatment of alcohol-induced pathology.

Authors

Jun Xu, Hsiao-Yen Ma, Xiao Liu, Sara Rosenthal, Jacopo Baglieri, Ryan McCubbin, Mengxi Sun, Yukinori Koyama, Cedric G. Geoffroy, Kaoru Saijo, Linshan Shang, Takahiro Nishio, Igor Maricic, Max Kreifeldt, Praveen Kusumanchi, Amanda Roberts, Binhai Zheng, Vipin Kumar, Karsten Zengler, Donald P. Pizzo, Mojgan Hosseini, Candice Contet, Christopher K. Glass, Suthat Liangpunsakul, Hidekazu Tsukamoto, Bin Gao, Michael Karin, David A. Brenner, George F. Koob, Tatiana Kisseleva

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 Total
Citations: 4 8 4 4 5 4 29
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (29)

Title and authors Publication Year
Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis
Yang J, Yang L, Wang Y, Huai L, Shi B, Zhang D, Xu W, Cui D
Molecular Medicine 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease.
Diaz LA, Morris S, Dave S, Kim SM, Sarik W, Richards L, Madamba E, Bettencourt R, Fulinara C, Pham T, Miller G, Carvalho-Gontijo Weber R, Momper JD, He F, Jain S, Jamieson C, Kisseleva T, Brenner D, Loomba R
Alimentary pharmacology & therapeutics 2025
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.
Seyhan D, Allaire M, Fu Y, Conti F, Wang XW, Gao B, Lafdil F
Cellular & molecular immunology 2025
Novel RORγt inverse agonists limit IL-17-mediated liver inflammation and fibrosis
Dabbaghizadeh A, Dion J, Maali Y, Fouda A, Bédard N, Evaristo G, Hassan GS, Tchervenkov J, Shoukry NH
The Journal of Immunology Author Choice 2025
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Floris G, Dabrowski KR, Zanda MT, Daws SE
2024
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Feng D, Hwang S, Guillot A, Wang Y, Guan Y, Chen C, Maccioni L, Gao B
Cellular and Molecular Gastroenterology and Hepatology 2024
IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study
Ho MF, Zhang C, Cohan JS, Tuncturk M, Heider RM, Coombes BJ, Biernacka J, Moon I, Skime M, Ho AM, Ngo Q, Skillon C, Croarkin PE, Oesterle TS, Karpyak VM, Li H, Weinshilboum RM
Brain, Behavior, and Immunity 2024
Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease
Abdelnabi MN, Hassan GS, Shoukry NH
Frontiers in Immunology 2024
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.
Rabiu L, Zhang P, Afolabi LO, Saliu MA, Dabai SM, Suleiman RB, Gidado KI, Ige MA, Ibrahim A, Zhang G, Wan X
Journal of gastroenterology 2024
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
Gao H, Jiang Y, Zeng G, Huda N, Thoudam T, Yang Z, Liangpunsakul S, Ma J
eGastroenterology 2024
Gut-liver Axis: Recent Concepts in Pathophysiology in Alcohol-Associated Liver Disease
Raya Tonetti F, Eguileor A, Mrdjen M, Pathak V, Travers J, Nagy LE, Llorente C
Hepatology (Baltimore, Md.) 2024
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Floris G, Dabrowski KR, Zanda MT, Daws SE
Molecular Psychiatry 2024
Pre-clinical and clinical evidence for suppression of alcohol intake by apremilast
Kolter Grigsby, Regina Mangieri, Amanda Roberts, Marcelo Lopez, Alexander Tran, Evan Firsick, Kayla Townsley, Alan Beneze, Jessica Bess, Toby K. Eisenstein, Joseph Meissler, John Light, Jenny Miller, Susan Quello, Farhad Shadan, Michael Skinner, Heather Aziz, Pamela Metten, Richard Morissett, John Crabbe, Marisa Roberto, Howard Becker, Barbara Mason, Angela Ozburn
Journal of Clinical Investigation 2023
A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin.
Kharbanda KK, Chokshi S, Tikhanovich I, Weinman SA, New-Aaron M, Ganesan M, Osna NA
Biology 2023
Sex differences in depression: An immunological perspective
Kropp DR, Hodes GE
Brain Research Bulletin 2023
Dihydromyricetin supplementation improves ethanol-induced lipid accumulation and inflammation
Janilkarn-Urena I, Idrissova A, Zhang M, VanDreal M, Sanghavi N, Skinner SG, Cheng S, Zhang Z, Watanabe J, Asatryan L, Cadenas E, Davies DL
Frontiers in Nutrition 2023
Maternal and Adult Interleukin-17A Exposure and Autism Spectrum Disorder
M Fujitani, H Miyajima, Y Otani, X Liu
Frontiers in Psychiatry 2022
Chronic and Binge Alcohol Ingestion Increases Truncated Oxidized Phosphatidylcholines in Mice Lungs Due to Increased Oxidative Stress
Appolonia CN, Wolf KM, Zawatsky CN, Cinar R
Frontiers in physiology 2022
Innate immune activation: Parallels in alcohol use disorder and Alzheimer’s disease
Ramos A, Joshi RS, Szabo G
Frontiers in molecular neuroscience 2022
Interplay Between Liver Type 1 Innate Lymphoid Cells and NK Cells Drives the Development of Alcoholic Steatohepatitis
Cheng C, Zhang Q, Li Y, Jiang J, Xie L, Shen H, Wu D, Zhang H, Zhang H, Wang X, Wu H, Xu J, Gui L, Li B, Ju C, Peng H, Yin S, Xu L
Cellular and Molecular Gastroenterology and Hepatology 2022
A perspective of intestinal immune-microbiome interactions in alcohol-associated Liver Disease
R Bruellman
International journal of biological sciences 2021
Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis
Y Li, J Zhang, J Shi, K Liu, X Wang, Y Jia, T He, K Shen, Y Wang, J Liu, W Zhang, T Wang, Z Zheng, D Hu
Stem Cell Research & Therapy 2021
IL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry
S Majumder, MJ McGeachy
Annual Review of Immunology 2021
Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
P Hirsova, AO Bamidele, H Wang, D Povero, XS Revelo
Frontiers in Endocrinology 2021
Synaptic effects of IL-1β and CRF in the central amygdala after protracted alcohol abstinence in male rhesus macaques
R Patel, F Varodayan, M Herman, V Jimenez, R Agnore, L Gao, M Bajo, V Carlson, N Walter, S Fei, K Grant, M Roberto
Neuropsychopharmacology 2021
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
Y He, S Hwang, YA Ahmed, D Feng, N Li, M Ribeiro, F Lafdil, T Kisseleva, G Szabo, B Gao
Cellular and Molecular Immunology 2020
Immune Response to an Acute Moderate Dose of Alcohol in Healthy Young Adults
MA Monnig, PS Lamb, JM Parra, PA Cioe, CM Martone, PM Monti, G Szabo
Alcohol and Alcoholism 2020
Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice
KB Grigsby, AM Savarese, P Metten, BJ Mason, YA Blednov, JC Crabbe, AR Ozburn
2020
Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice
K Frank, S Abeynaike, R Nikzad, RR Patel, AJ Roberts, M Roberto, S Paust, J Wang
PloS one 2020

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts